pH Pharma passed technical evaluation

  • Received “Pass” from two tech evaluation agencies… Target to file preliminary review application to KOSDAQ
  • Expanding global new drug development platform through IPO. Accelerating innovation for new drug development and business development

(For more information, please refer to the link below)

https://www.hankyung.com/it/article/201912276015i